2015
DOI: 10.1016/j.ghir.2015.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Growth hormone and the risk of atherosclerosis in growth hormone-deficient children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 37 publications
0
11
0
2
Order By: Relevance
“…Childhood exposure to O3 may be a novel risk factor for CIMT in a healthy population of college students [ 143 ]. Additionally, higher CIMT was associated with the development of chronic kidney disease [ 144 ], growth hormone deficiency [ 145 ], beta-thalassemia minor [ 146 ], preeclampsia [ 142 ] and menopause transition [ 147 ]. However, recent studies could not show associations of elevated parathyroid hormone (PTH) concentrations [ 136 ] and normal-tension glaucoma [ 48 ] with altered CIMT.…”
Section: The Associations Between Cimt and Novel Risk Factorsmentioning
confidence: 99%
“…Childhood exposure to O3 may be a novel risk factor for CIMT in a healthy population of college students [ 143 ]. Additionally, higher CIMT was associated with the development of chronic kidney disease [ 144 ], growth hormone deficiency [ 145 ], beta-thalassemia minor [ 146 ], preeclampsia [ 142 ] and menopause transition [ 147 ]. However, recent studies could not show associations of elevated parathyroid hormone (PTH) concentrations [ 136 ] and normal-tension glaucoma [ 48 ] with altered CIMT.…”
Section: The Associations Between Cimt and Novel Risk Factorsmentioning
confidence: 99%
“…The CAVI data are presented as mean±SD (standard deviation). that sleep induces growth hormone release, which, in turn, protects against atherosclerosis and carotid intima-media thickness in children 32) . Therefore, long sleep may reduce CAVI in children.…”
Section: Resultsmentioning
confidence: 97%
“…Un aumento de las cifras de triglicéridos y disminución de las LDL tras un año de tratamiento fue notificado por Witkouska-Sedek et al 34 Algunos estudios no encontraron cambios significativos en el perfil lipídico después de 12 meses de tratamiento. 6,17,36,46 La mayoría de los estudios 8,18,28,37,47,43 al comparar los niños con DGH con niños sanos señalan un perfil lipídico desfavorable en los primeros. En algunas investigaciones 17,36 no se detectan diferencias.…”
Section: Discussionunclassified